IndiaOne Finance - Company Dashboard

Governance Classic Home

Piramal Pharma LtdPharmaceuticalsINE0DK501011Consolidated₹208.00+3.50 (+1.71%)Jun-26

Valuation

Market Cap₹27.71K Cr

TTM PE-87.83x

Forward PE-96.37x

PEG21.69

Book Value₹61.31

P/B3.40x

TTM EPS₹-2.37

Fwd EPS₹-2.16

TTM Revenue₹9.21K Cr

TTM PAT₹-313.62 Cr

TTM EBITDA₹1.01K Cr

TTM EBIT₹152.62 Cr

Last Qtr PAT₹-69.39 Cr

Last Qtr EBITDA₹195.20 Cr

Last Qtr EBIT₹-28.35 Cr

Profitability

ROE-3.84%

ROCE1.75%

TTM NPM-3.41%

TTM EBITDA %10.97%

Curr OPM-2.94%

Last OPM-0.32%

Curr NPM—

Last NPM—

Curr EPS₹-0.52

Last EPS₹-0.07

Balance sheet

Equity₹1,327.16 Cr

Reserve₹6.84K Cr

Total Debt₹5,638.48 Cr

D/E0.69x

Interest %-126.93%

Curr Interest₹88.08 Cr

Price / range

Close₹208.16

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+1.69%

1W-1.54%

1M-1.21%

3M+29.84%

6M+45.30%

1Y+2.39%

2Y-8.64%

3Y+105.90%

5Y—

Diwali+22.52%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	1,124.95+16.0%	1,489.06	1,195.81	1,127.26	969.88	4,782.01
Other Income	114.63	183.69	96.15	201.97	180.92	662.73
Total Income	1,239.58+7.7%	1,672.75	1,291.96	1,329.23	1,150.80	5,444.74
Interest	16.36	19.50	16.84	20.38	23.23	79.95
Expenditure	-1,090.10-8.1%	-1,275.33	-1,110.09	-1,081.82	-1,008.22	-4,475.46
PBDT	0	0	0	0	0	0
EBITDA	116.94+163.8%	303.35	167.25	127.07	44.33	642
Depreciation	-65.73	-70.12	-64.69	-61.25	-59.44	-255.50
EBIT	51.21+438.9%	233.23	102.56	65.82	-15.11	386.50
PBT	149.48+4.8%	331.85	154.93	247.41	142.58	876.77
Tax	-36	-70.22	-26.02	-51.08	-29.44	-176.76
Equity	1,327.35	1,327.16	1,325.83	0	1,324.82	1,327.16
OPM	12.06	19.84	11.99	21.95	12.39	16.10
Net Profit	113.48+0.3%	261.63	128.91	196.33	113.14	700.01
NPM	9.15	15.64	9.98	17.42	9.83	12.86
EPS	0.85+0.0%	1.97	0.97	1.48	0.85	5.28

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	4,782.01-9.5%	5,285.71+20.4%	4,390.11+27.5%	3,443.22
Other Income	662.73	207.35	202.06	341.07
Total Income	5,444.74-0.9%	5,493.06+19.6%	4,592.17+21.3%	3,784.29
Expenditure	-4,475.46+2.3%	-4,581.92-12.2%	-4,084.55-11.8%	-3,653.64
Interest	-79.95	-114.56	-107.10	-115.87
PBDT	0	0	0	0
EBITDA	642-38.3%	1,040.44+68.4%	617.92+533.6%	97.53
Depreciation	-255.50	-222.09	-205.26	-192.08
EBIT	386.50-52.8%	818.35+98.3%	412.66+536.4%	-94.55
PBT	876.77-3.8%	911.14+79.5%	507.62+310.4%	123.69
Tax	-176.76	-219.74	-116.40	-54.19
Equity	1,327.16	1,324.35	0	0
OPM (%)	16.10	16.59	11.00	3.00
Net Profit	700.01+1.2%	691.40+76.7%	391.22+462.9%	69.50
NPM (%)	12.86	12.59	9.00	2.00
EPS (Rs)	5.28+1.1%	5.22+71.1%	3.05+425.9%	0.58
CEPS	5.25	5.20	3.05	0.58

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	2,269.92+17.4%	2,751.77	2,139.87	2,043.72	1,933.71	8,869.08
Other Income	89.41	46.06	43.24	65.60	58.40	213.30
Total Income	2,359.33+18.4%	2,797.83	2,183.11	2,109.32	1,992.11	9,082.38
Interest	88.08	82.99	89.24	82.42	86.15	340.80
Expenditure	-2,386.35-13.1%	-2,592.63	-2,246.12	-2,170.29	-2,110.44	-9,119.50
PBDT	0	0	0	0	0	0
EBITDA	195.20+82.9%	460.51	195.73	158.69	106.70	921.62
Depreciation	-223.55	-218.38	-212.74	-202.84	-197.28	-831.24
EBIT	-28.35+68.7%	242.13	-17.01	-44.15	-90.58	90.38
PBT	-27.02+72.3%	29.43	-104.12	0	-97.59	-233.26
Tax	-61.93	-51.83	-42.33	-53.04	-2.68	-149.88
Equity	1,327.35	1,327.16	1,325.83	0	1,324.82	1,327.16
OPM	-1.15	1.05	-4.77	0.00	-4.90	-2.57
Net Profit	-69.39+15.1%	-8.82	-136.19	-99.22	-81.70	-325.94
NPM	-2.94	-0.32	-6.24	-4.70	-4.10	-3.59
EPS	-0.52+16.1%	-0.07	-1.03	-0.75	-0.62	0

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23
Revenue	8,869.08-3.1%	9,151.18+12.0%	8,171.16+15.4%	7,081.55
Other Income	213.30	134.81	175.39	225.11
Total Income	9,082.38-2.2%	9,285.99+11.3%	8,346.55+14.2%	7,306.66
Expenditure	-9,119.50-2.0%	-8,944.28-9.6%	-8,163.96-9.2%	-7,474.18
Interest	-340.80	-421.59	-448.49	-344.18
PBDT	0	0	0	0
EBITDA	921.62-36.2%	1,444.83+20.8%	1,196.26+90.4%	628.24
Depreciation	-831.24	-816.34	-740.57	-676.69
EBIT	90.38-85.6%	628.49+37.9%	455.69+1040.5%	-48.45
PBT	-233.26-168.3%	341.71+185.2%	119.80+168.7%	-174.48
Tax	-149.88	-323.51	-161.47	-66.31
Equity	1,327.16	1,324.35	0	0
OPM (%)	-2.57	3.68	1.44	-2.39
Net Profit	-325.94-457.7%	91.13+411.4%	17.82+109.6%	-186.46
NPM (%)	-3.59	0.98	0.21	-2.55
EPS (Rs)	0-100.0%	0.69+392.9%	0.14+108.9%	-1.57
CEPS	0	0.68	0.14	-1.57

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2025	Final Dividend	0.14	16 Jul 2025
2024	Final Dividend	0.11	12 Jul 2024

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split